미도드린 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "미도드린" in Korean language version.

refsWebsite
Global rank Korean rank
4th place
4th place
2nd place
3rd place
1st place
1st place
800th place
1,296th place
49th place
110th place
low place
low place
2,446th place
1,801st place
406th place
621st place
1,610th place
869th place
1,182nd place
1,821st place

doi.org (Global: 2nd place; Korean: 3rd place)

dx.doi.org

  • Izcovich, A.; Gonzalez Malla, C.; Manzotti, M.; Catalano, H. N.; Guyatt, G. (2014년 8월 22일). “Midodrine for orthostatic hypotension and recurrent reflex syncope: A systematic review”. 《Neurology》 83 (13): 1170–1177. doi:10.1212/WNL.0000000000000815. PMID 25150287. 
  • “Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials”. 《Ann Pharmacother》 52 (12): 1182–1194. July 2018. doi:10.1177/1060028018786954. PMID 29972032. 
  • Prakash, S; Garg, AX; Heidenheim, AP; House, AA (Oct 2004). “Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review.”. 《Nephrology, Dialysis, Transplantation》 19 (10): 2553–8. doi:10.1093/ndt/gfh420. PMID 15280522. 
  • Karwa, R.; Woodis, C B. (2009년 3월 31일). “Midodrine and Octreotide in Treatment of Cirrhosis-Related Hemodynamic Complications”. 《Annals of Pharmacotherapy》 43 (4): 692–699. doi:10.1345/aph.1L373. PMID 19299324. 

espacenet.com (Global: 800th place; Korean: 1,296th place)

worldwide.espacenet.com

mayoclinic.org (Global: 1,610th place; Korean: 869th place)

nih.gov (Global: 4th place; Korean: 4th place)

ncbi.nlm.nih.gov

  • Izcovich, A.; Gonzalez Malla, C.; Manzotti, M.; Catalano, H. N.; Guyatt, G. (2014년 8월 22일). “Midodrine for orthostatic hypotension and recurrent reflex syncope: A systematic review”. 《Neurology》 83 (13): 1170–1177. doi:10.1212/WNL.0000000000000815. PMID 25150287. 
  • “Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials”. 《Ann Pharmacother》 52 (12): 1182–1194. July 2018. doi:10.1177/1060028018786954. PMID 29972032. 
  • Prakash, S; Garg, AX; Heidenheim, AP; House, AA (Oct 2004). “Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review.”. 《Nephrology, Dialysis, Transplantation》 19 (10): 2553–8. doi:10.1093/ndt/gfh420. PMID 15280522. 
  • Karwa, R.; Woodis, C B. (2009년 3월 31일). “Midodrine and Octreotide in Treatment of Cirrhosis-Related Hemodynamic Complications”. 《Annals of Pharmacotherapy》 43 (4): 692–699. doi:10.1345/aph.1L373. PMID 19299324. 

dailymed.nlm.nih.gov

patents.google.com (Global: 1,182nd place; Korean: 1,821st place)

prnewswire.com (Global: 406th place; Korean: 621st place)

reuters.com (Global: 49th place; Korean: 110th place)

uk.reuters.com

theheart.org (Global: low place; Korean: low place)

  • O'Riordan, Michael. “FDA recommends withdrawal of midodrine”. 《Food and Drug Administration. FDA proposes withdrawal of low blood pressure drug [press release]. August 16, 2010.》. TheHeart.org. 2011년 4월 1일에 확인함. 

utah.edu (Global: 2,446th place; Korean: 1,801st place)

healthcare.utah.edu

web.archive.org (Global: 1st place; Korean: 1st place)